| Financial Year |
March 31 2023 |
| Monetary Funds |
-- |
| Held-for-trading Financial Assets |
238,745,169.68 |
| Notes Receivable |
12,292,941.00 |
| Accounts Receivable |
628,162,992.58 |
| Advances to Suppliers |
29,661,202.59 |
| Other Receivables |
114,711,138.13 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
428,289,462.68 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
136,033.34 |
| Total Current Assets |
1,771,578,307.30 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
8,553,289.18 |
| Investment Properties |
-- |
| Fixed Assetes |
62,171,168.51 |
| Under-construction Projects |
138,908,329.25 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
90,821,046.68 |
| R&D expenses |
-- |
| Goodwill |
3,547,210.22 |
| Long-Term Deferred and Prepaid Expenses |
159,094.77 |
| Deferred Income Tax Assets |
93,630,440.80 |
| Other Non-Current Assets |
95,349,500.00 |
| Sub-Total of Non-Current Assets |
576,036,260.69 |
| Total Assets |
2,347,614,567.99 |
| Short-Term Loans |
25,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
12,948,935.37 |
| Accounts Payable |
211,867,342.56 |
| Accounts Received In Advance |
2,182,736.16 |
| Employee Compensation Payable |
21,287,570.77 |
| Taxes Payable |
23,728,718.56 |
| Interest Payable |
-- |
| Dividend Payable |
1,000,000.00 |
| Other payables |
60,390,259.40 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,318,450.52 |
| Other Current Liabilities |
20,286,800.14 |
| Sub-Total of Current Liabilities |
511,475,324.68 |
| Long-term Loans |
-- |
| Bonds Payable |
208,065,132.78 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,510,000.00 |
| Deferred Income Tax Liabilities |
14,641,669.06 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
253,059,763.75 |
| Total Liabilities |
764,535,088.43 |
| Paid-In Capital(Or Share Stock) |
188,265,025.00 |
| Capital Surplus |
835,541,007.82 |
| Surplus Reserve |
67,068,482.49 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
437,574,263.66 |
| Minority Stockholder's Interest |
27,879,022.17 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,555,200,457.39 |
| Owner's Equity（Stockholder's Equity） |
1,583,079,479.56 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,347,614,567.99 |
